CompletedNCT02081287
Inositol Hexaphosphate Compared With Lamotrigine for Bipolarity
About this title
Read the official source — NCT02081287Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- San DiegoSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateMay 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- San Diego Veterans Healthcare System
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT02081287
- Official title
Show the full official title
Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Diego
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is San Diego Veterans Healthcare System.
Did this study involve medication?
Yes. The study involved medication, including IP6 and lamotrigine.
Who was this study for?
Listed age limits: 18 years to 75 years.
